We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
108 hedge funds and large institutions have $365M invested in Amphastar Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 34 increasing their positions, 48 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
23% more capital invested
Capital invested by funds: $296M → $365M (+$69.1M)
0.21% more ownership
Funds ownership: 44.49% → 44.7% (+0.21%)
7% less funds holding
Funds holding: 116 → 108 (-8)
29% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 48
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $16K
Holders
108
Holders Change
-8
Holders Change %
-6.9%
% of All Funds
2.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
34
Reduced
48
Closed
16
Calls
–
Puts
$16K
Net Calls
-$16K
Net Calls Change
+$114K
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$18M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.29M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.73M |
| 4 |
UBS AM
Chicago,
Illinois
|
+$3.39M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.78M |
